

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 5.49679147 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.49679147 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.45184139 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.86706040 |
| 5 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.21773647 |
| 6 | macrophage activation involved in immune response (GO:0002281) | 4.10009143 |
| 7 | negative regulation of T cell mediated immunity (GO:0002710) | 3.99009147 |
| 8 | detection of other organism (GO:0098543) | 3.94526903 |
| 9 | cellular response to type I interferon (GO:0071357) | 3.84744765 |
| 10 | type I interferon signaling pathway (GO:0060337) | 3.84744765 |
| 11 | response to type I interferon (GO:0034340) | 3.83588076 |
| 12 | detection of bacterium (GO:0016045) | 3.81041295 |
| 13 | regulation of B cell receptor signaling pathway (GO:0050855) | 3.76763557 |
| 14 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.76023508 |
| 15 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.72012651 |
| 16 | immunoglobulin mediated immune response (GO:0016064) | 3.66325659 |
| 17 | NIK/NF-kappaB signaling (GO:0038061) | 3.64920829 |
| 18 | regulation of RIG-I signaling pathway (GO:0039535) | 3.62122338 |
| 19 | negative thymic T cell selection (GO:0045060) | 3.58430354 |
| 20 | detection of molecule of bacterial origin (GO:0032490) | 3.54836665 |
| 21 | negative T cell selection (GO:0043383) | 3.54203557 |
| 22 | microglial cell activation (GO:0001774) | 3.53716662 |
| 23 | detection of external biotic stimulus (GO:0098581) | 3.52797775 |
| 24 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.52397161 |
| 25 | response to host immune response (GO:0052572) | 3.50280732 |
| 26 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.50280732 |
| 27 | cellular extravasation (GO:0045123) | 3.47424884 |
| 28 | regulation of T cell tolerance induction (GO:0002664) | 3.46651616 |
| 29 | T cell migration (GO:0072678) | 3.44432675 |
| 30 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.43804785 |
| 31 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.43762715 |
| 32 | positive T cell selection (GO:0043368) | 3.42443945 |
| 33 | regulation of regulatory T cell differentiation (GO:0045589) | 3.38397260 |
| 34 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.38017275 |
| 35 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.37693601 |
| 36 | regulation of gamma-delta T cell activation (GO:0046643) | 3.37490809 |
| 37 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.36727231 |
| 38 | cellular response to interferon-beta (GO:0035458) | 3.35443186 |
| 39 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.33304347 |
| 40 | myeloid cell activation involved in immune response (GO:0002275) | 3.28076334 |
| 41 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.27405722 |
| 42 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.26382690 |
| 43 | positive regulation of interferon-alpha production (GO:0032727) | 3.26082410 |
| 44 | regulation of tolerance induction (GO:0002643) | 3.24712732 |
| 45 | positive regulation of antigen processing and presentation (GO:0002579) | 3.21772916 |
| 46 | defense response to protozoan (GO:0042832) | 3.21554955 |
| 47 | positive regulation of B cell differentiation (GO:0045579) | 3.19026709 |
| 48 | tolerance induction (GO:0002507) | 3.17272283 |
| 49 | regulation of B cell differentiation (GO:0045577) | 3.17147268 |
| 50 | response to host (GO:0075136) | 3.16425202 |
| 51 | response to host defenses (GO:0052200) | 3.16425202 |
| 52 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.16425202 |
| 53 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.14602520 |
| 54 | leukocyte aggregation (GO:0070486) | 3.14600629 |
| 55 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.12168226 |
| 56 | activated T cell proliferation (GO:0050798) | 3.11921680 |
| 57 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.11079852 |
| 58 | detection of biotic stimulus (GO:0009595) | 3.10906425 |
| 59 | B cell receptor signaling pathway (GO:0050853) | 3.09482003 |
| 60 | cellular response to exogenous dsRNA (GO:0071360) | 3.09249492 |
| 61 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.08173002 |
| 62 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.07840933 |
| 63 | regulation of interferon-alpha production (GO:0032647) | 3.07793410 |
| 64 | regulation of response to interferon-gamma (GO:0060330) | 3.05119324 |
| 65 | positive thymic T cell selection (GO:0045059) | 3.04847448 |
| 66 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.03237655 |
| 67 | B cell mediated immunity (GO:0019724) | 3.02337428 |
| 68 | myeloid dendritic cell activation (GO:0001773) | 3.02285556 |
| 69 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.01795862 |
| 70 | cellular response to zinc ion (GO:0071294) | 3.01205145 |
| 71 | macrophage activation (GO:0042116) | 2.97714355 |
| 72 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.97384745 |
| 73 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.97384745 |
| 74 | response to protozoan (GO:0001562) | 2.97131671 |
| 75 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.96586151 |
| 76 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.94476858 |
| 77 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.94476858 |
| 78 | interferon-gamma secretion (GO:0072643) | 2.94208638 |
| 79 | regulation of antigen processing and presentation (GO:0002577) | 2.93254180 |
| 80 | positive regulation of tolerance induction (GO:0002645) | 2.92868839 |
| 81 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.92862557 |
| 82 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 2.92572041 |
| 83 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.92353470 |
| 84 | response to interferon-beta (GO:0035456) | 2.91926285 |
| 85 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.90796181 |
| 86 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.89824583 |
| 87 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 2.88766166 |
| 88 | positive regulation of interferon-beta production (GO:0032728) | 2.86349243 |
| 89 | ribosomal small subunit assembly (GO:0000028) | 2.86279169 |
| 90 | response to interleukin-15 (GO:0070672) | 2.85690737 |
| 91 | response to peptidoglycan (GO:0032494) | 2.85482093 |
| 92 | neutrophil activation involved in immune response (GO:0002283) | 2.84834474 |
| 93 | interferon-gamma production (GO:0032609) | 2.84288740 |
| 94 | thymic T cell selection (GO:0045061) | 2.81749482 |
| 95 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.81680232 |
| 96 | natural killer cell mediated immunity (GO:0002228) | 2.81680232 |
| 97 | myeloid dendritic cell differentiation (GO:0043011) | 2.77308359 |
| 98 | mast cell activation (GO:0045576) | 2.77034797 |
| 99 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.75497592 |
| 100 | positive regulation of humoral immune response (GO:0002922) | 2.72316091 |
| 101 | positive regulation of interleukin-2 production (GO:0032743) | 2.72014303 |
| 102 | cellular response to interleukin-15 (GO:0071350) | 2.71918975 |
| 103 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.70623704 |
| 104 | T cell selection (GO:0045058) | 2.70341246 |
| 105 | respiratory burst (GO:0045730) | 2.68987892 |
| 106 | positive regulation of isotype switching (GO:0045830) | 2.68787600 |
| 107 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.68520664 |
| 108 | positive regulation by symbiont of host defense response (GO:0052509) | 2.66444033 |
| 109 | modulation by symbiont of host defense response (GO:0052031) | 2.66444033 |
| 110 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.66444033 |
| 111 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.66444033 |
| 112 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.66444033 |
| 113 | modulation by symbiont of host immune response (GO:0052553) | 2.66444033 |
| 114 | negative regulation of viral genome replication (GO:0045071) | 2.65625603 |
| 115 | neutrophil activation (GO:0042119) | 2.63060754 |
| 116 | positive regulation of defense response to virus by host (GO:0002230) | 2.62497973 |
| 117 | response to interferon-alpha (GO:0035455) | 2.60506548 |
| 118 | positive regulation of interleukin-12 production (GO:0032735) | 2.56891459 |
| 119 | response to muramyl dipeptide (GO:0032495) | 2.56289147 |
| 120 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 2.56247161 |
| 121 | mature B cell differentiation (GO:0002335) | 2.55733353 |
| 122 | T cell costimulation (GO:0031295) | 2.55666886 |
| 123 | natural killer cell activation (GO:0030101) | 2.54060399 |
| 124 | cellular response to interferon-gamma (GO:0071346) | 2.53569787 |
| 125 | lymphocyte costimulation (GO:0031294) | 2.51535030 |
| 126 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.51009193 |
| 127 | granulocyte activation (GO:0036230) | 2.50388426 |
| 128 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 2.48183423 |
| 129 | negative regulation of cell killing (GO:0031342) | 2.46799215 |
| 130 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.46799215 |
| 131 | negative regulation of interleukin-12 production (GO:0032695) | 2.43348780 |
| 132 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.42971105 |
| 133 | positive regulation of B cell mediated immunity (GO:0002714) | 2.42790045 |
| 134 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.42790045 |
| 135 | DNA replication checkpoint (GO:0000076) | 2.42195764 |
| 136 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.41959951 |
| 137 | T cell homeostasis (GO:0043029) | 2.39668472 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.82193242 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.05435534 |
| 3 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.41825250 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.13038410 |
| 5 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.53934030 |
| 6 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.42483037 |
| 7 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 3.02148787 |
| 8 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.02076714 |
| 9 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.01635469 |
| 10 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.55902965 |
| 11 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.54938154 |
| 12 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.52497313 |
| 13 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.50955229 |
| 14 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.50253080 |
| 15 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.36822624 |
| 16 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.32659611 |
| 17 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.32516357 |
| 18 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.28690257 |
| 19 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.28075805 |
| 20 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.27434072 |
| 21 | MYC_22102868_ChIP-Seq_BL_Human | 2.23778945 |
| 22 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.17890884 |
| 23 | MYB_26560356_Chip-Seq_TH2_Human | 2.16874308 |
| 24 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.10611150 |
| 25 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.04519499 |
| 26 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.04095861 |
| 27 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.01980049 |
| 28 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.01249744 |
| 29 | * SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.00427537 |
| 30 | MYB_26560356_Chip-Seq_TH1_Human | 1.98285043 |
| 31 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.96260508 |
| 32 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.93252385 |
| 33 | MAF_26560356_Chip-Seq_TH1_Human | 1.90409305 |
| 34 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.88775754 |
| 35 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.87901253 |
| 36 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.82913168 |
| 37 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.81879979 |
| 38 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74014443 |
| 39 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.73863102 |
| 40 | * VDR_23849224_ChIP-Seq_CD4+_Human | 1.72884900 |
| 41 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.71322866 |
| 42 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.65629808 |
| 43 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.63044803 |
| 44 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.56255122 |
| 45 | UTX_26944678_Chip-Seq_JUKART_Human | 1.55561391 |
| 46 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.55091422 |
| 47 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.53671760 |
| 48 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.53605966 |
| 49 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51041438 |
| 50 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.50251044 |
| 51 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.49055382 |
| 52 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.49008622 |
| 53 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.47794980 |
| 54 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.43903856 |
| 55 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.42579755 |
| 56 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.40635913 |
| 57 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.38441529 |
| 58 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.36804897 |
| 59 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.35753474 |
| 60 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.35132691 |
| 61 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.34371252 |
| 62 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.31947182 |
| 63 | MAF_26560356_Chip-Seq_TH2_Human | 1.30768816 |
| 64 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.29417607 |
| 65 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.29215396 |
| 66 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.28404126 |
| 67 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.27933865 |
| 68 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.27123565 |
| 69 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.21848733 |
| 70 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.21545950 |
| 71 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.19473641 |
| 72 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.19024072 |
| 73 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.18615815 |
| 74 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.17664705 |
| 75 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.16895946 |
| 76 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.16506510 |
| 77 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16323048 |
| 78 | GATA1_22025678_ChIP-Seq_K562_Human | 1.15218783 |
| 79 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.14921500 |
| 80 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12474283 |
| 81 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.10940130 |
| 82 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.10631146 |
| 83 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.10523784 |
| 84 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10191576 |
| 85 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.09379049 |
| 86 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.08949288 |
| 87 | GATA3_26560356_Chip-Seq_TH2_Human | 1.08740548 |
| 88 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.08561011 |
| 89 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.08549953 |
| 90 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.07699064 |
| 91 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.05974460 |
| 92 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.05725772 |
| 93 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.04566486 |
| 94 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.04504292 |
| 95 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.03770776 |
| 96 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.02210550 |
| 97 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02195300 |
| 98 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00294348 |
| 99 | * SMRT_27268052_Chip-Seq_Bcells_Human | 0.98939247 |
| 100 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.98858887 |
| 101 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98225253 |
| 102 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97580573 |
| 103 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96683758 |
| 104 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.95250120 |
| 105 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.94712158 |
| 106 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.93965355 |
| 107 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93740482 |
| 108 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93630592 |
| 109 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.93541319 |
| 110 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 0.93143563 |
| 111 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90015570 |
| 112 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 0.89304824 |
| 113 | GATA1_19941826_ChIP-Seq_K562_Human | 0.89051017 |
| 114 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.88405144 |
| 115 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.87925994 |
| 116 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.87284872 |
| 117 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.87040506 |
| 118 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86314066 |
| 119 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85272365 |
| 120 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.83737849 |
| 121 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.80587779 |
| 122 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.77559928 |
| 123 | GATA3_26560356_Chip-Seq_TH1_Human | 0.76794717 |
| 124 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.76461294 |
| 125 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.76141928 |
| 126 | GATA2_19941826_ChIP-Seq_K562_Human | 0.75719361 |
| 127 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.75663568 |
| 128 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.72052613 |
| 129 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.71780832 |
| 130 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.70949286 |
| 131 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.70085001 |
| 132 | P300_27268052_Chip-Seq_Bcells_Human | 0.69911183 |
| 133 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.65164669 |
| 134 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.64720423 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.73823748 |
| 2 | MP0005671_abnormal_response_to | 3.52351752 |
| 3 | MP0000685_abnormal_immune_system | 3.33218755 |
| 4 | MP0009785_altered_susceptibility_to | 3.14290558 |
| 5 | MP0001800_abnormal_humoral_immune | 3.10709173 |
| 6 | MP0005387_immune_system_phenotype | 2.96977991 |
| 7 | MP0001790_abnormal_immune_system | 2.96977991 |
| 8 | MP0002396_abnormal_hematopoietic_system | 2.88168696 |
| 9 | MP0005000_abnormal_immune_tolerance | 2.87113552 |
| 10 | MP0003763_abnormal_thymus_physiology | 2.86414692 |
| 11 | MP0002452_abnormal_antigen_presenting | 2.76311723 |
| 12 | MP0002723_abnormal_immune_serum | 2.69771049 |
| 13 | MP0002148_abnormal_hypersensitivity_rea | 2.67427046 |
| 14 | MP0005025_abnormal_response_to | 2.66229779 |
| 15 | MP0001819_abnormal_immune_cell | 2.58048842 |
| 16 | MP0002420_abnormal_adaptive_immunity | 2.57544299 |
| 17 | MP0003436_decreased_susceptibility_to | 2.56202340 |
| 18 | MP0003693_abnormal_embryo_hatching | 2.52142802 |
| 19 | MP0002398_abnormal_bone_marrow | 2.46367194 |
| 20 | MP0002166_altered_tumor_susceptibility | 2.37181838 |
| 21 | MP0008057_abnormal_DNA_replication | 2.34645332 |
| 22 | MP0002419_abnormal_innate_immunity | 2.34268020 |
| 23 | MP0009333_abnormal_splenocyte_physiolog | 2.24186855 |
| 24 | MP0000716_abnormal_immune_system | 2.22773088 |
| 25 | MP0002006_tumorigenesis | 2.18513949 |
| 26 | MP0006082_CNS_inflammation | 2.14180529 |
| 27 | MP0003724_increased_susceptibility_to | 2.05706173 |
| 28 | MP0000689_abnormal_spleen_morphology | 2.02646916 |
| 29 | MP0002405_respiratory_system_inflammati | 1.96593935 |
| 30 | MP0002722_abnormal_immune_system | 1.94449034 |
| 31 | MP0004808_abnormal_hematopoietic_stem | 1.91859806 |
| 32 | MP0010094_abnormal_chromosome_stability | 1.89703104 |
| 33 | MP0001545_abnormal_hematopoietic_system | 1.88532925 |
| 34 | MP0005397_hematopoietic_system_phenotyp | 1.88532925 |
| 35 | MP0002429_abnormal_blood_cell | 1.88089159 |
| 36 | MP0003303_peritoneal_inflammation | 1.82189415 |
| 37 | MP0005464_abnormal_platelet_physiology | 1.81260199 |
| 38 | MP0010155_abnormal_intestine_physiology | 1.79744164 |
| 39 | MP0003111_abnormal_nucleus_morphology | 1.76674945 |
| 40 | MP0001853_heart_inflammation | 1.75835472 |
| 41 | MP0003077_abnormal_cell_cycle | 1.72846074 |
| 42 | MP0001845_abnormal_inflammatory_respons | 1.65481536 |
| 43 | MP0000703_abnormal_thymus_morphology | 1.63561108 |
| 44 | MP0005310_abnormal_salivary_gland | 1.62809556 |
| 45 | MP0004947_skin_inflammation | 1.62334016 |
| 46 | MP0001873_stomach_inflammation | 1.61404730 |
| 47 | MP0004510_myositis | 1.56960701 |
| 48 | MP0000490_abnormal_crypts_of | 1.50960957 |
| 49 | MP0008058_abnormal_DNA_repair | 1.50715211 |
| 50 | MP0009278_abnormal_bone_marrow | 1.37067986 |
| 51 | MP0010307_abnormal_tumor_latency | 1.30194048 |
| 52 | MP0008007_abnormal_cellular_replicative | 1.29727340 |
| 53 | MP0008469_abnormal_protein_level | 1.27659436 |
| 54 | MP0004957_abnormal_blastocyst_morpholog | 1.25839864 |
| 55 | MP0000465_gastrointestinal_hemorrhage | 1.24016769 |
| 56 | MP0002019_abnormal_tumor_incidence | 1.20405319 |
| 57 | MP0000858_altered_metastatic_potential | 1.20346644 |
| 58 | MP0003866_abnormal_defecation | 1.20051302 |
| 59 | MP0005174_abnormal_tail_pigmentation | 1.16274854 |
| 60 | MP0003448_altered_tumor_morphology | 1.16018247 |
| 61 | MP0001533_abnormal_skeleton_physiology | 1.12387228 |
| 62 | MP0004883_abnormal_blood_vessel | 1.12049308 |
| 63 | MP0008260_abnormal_autophagy | 1.11621859 |
| 64 | MP0003045_fibrosis | 1.05583577 |
| 65 | MP0005075_abnormal_melanosome_morpholog | 1.04694469 |
| 66 | MP0009764_decreased_sensitivity_to | 1.01184240 |
| 67 | MP0002163_abnormal_gland_morphology | 0.95556287 |
| 68 | MP0002132_abnormal_respiratory_system | 0.95413090 |
| 69 | MP0005166_decreased_susceptibility_to | 0.95291232 |
| 70 | MP0005451_abnormal_body_composition | 0.95136156 |
| 71 | MP0005058_abnormal_lysosome_morphology | 0.94642049 |
| 72 | MP0003075_altered_response_to | 0.92692072 |
| 73 | MP0005164_abnormal_response_to | 0.90956247 |
| 74 | MP0002933_joint_inflammation | 0.88713030 |
| 75 | MP0002095_abnormal_skin_pigmentation | 0.87452448 |
| 76 | MP0000015_abnormal_ear_pigmentation | 0.85326410 |
| 77 | MP0001663_abnormal_digestive_system | 0.83734535 |
| 78 | MP0000313_abnormal_cell_death | 0.80605589 |
| 79 | MP0003300_gastrointestinal_ulcer | 0.75982945 |
| 80 | MP0000350_abnormal_cell_proliferation | 0.73995194 |
| 81 | MP0009765_abnormal_xenobiotic_induced | 0.73929036 |
| 82 | MP0005390_skeleton_phenotype | 0.71307294 |
| 83 | MP0008004_abnormal_stomach_pH | 0.71213881 |
| 84 | MP0003786_premature_aging | 0.71012723 |
| 85 | MP0009763_increased_sensitivity_to | 0.70716642 |
| 86 | MP0000343_altered_response_to | 0.70515495 |
| 87 | MP0002138_abnormal_hepatobiliary_system | 0.70311346 |
| 88 | MP0003806_abnormal_nucleotide_metabolis | 0.66599875 |
| 89 | MP0002277_abnormal_respiratory_mucosa | 0.65813001 |
| 90 | MP0008877_abnormal_DNA_methylation | 0.65776495 |
| 91 | MP0003690_abnormal_glial_cell | 0.65378933 |
| 92 | MP0009840_abnormal_foam_cell | 0.65322574 |
| 93 | MP0003195_calcinosis | 0.64859276 |
| 94 | MP0003191_abnormal_cellular_cholesterol | 0.64281383 |
| 95 | MP0003183_abnormal_peptide_metabolism | 0.63680943 |
| 96 | MP0000249_abnormal_blood_vessel | 0.62931638 |
| 97 | MP0002693_abnormal_pancreas_physiology | 0.62645366 |
| 98 | MP0002332_abnormal_exercise_endurance | 0.62547448 |
| 99 | MP0000604_amyloidosis | 0.62334473 |
| 100 | MP0001851_eye_inflammation | 0.62248251 |
| 101 | MP0002009_preneoplasia | 0.61652062 |
| 102 | MP0003718_maternal_effect | 0.59826582 |
| 103 | MP0003172_abnormal_lysosome_physiology | 0.59566216 |
| 104 | MP0001986_abnormal_taste_sensitivity | 0.58665713 |
| 105 | MP0000371_diluted_coat_color | 0.58400096 |
| 106 | MP0003828_pulmonary_edema | 0.58214995 |
| 107 | MP0003795_abnormal_bone_structure | 0.56637970 |
| 108 | MP0004381_abnormal_hair_follicle | 0.55810369 |
| 109 | MP0003646_muscle_fatigue | 0.55493011 |
| 110 | MP0010352_gastrointestinal_tract_polyps | 0.54907253 |
| 111 | MP0003787_abnormal_imprinting | 0.54644450 |
| 112 | MP0005621_abnormal_cell_physiology | 0.53630311 |
| 113 | MP0002998_abnormal_bone_remodeling | 0.53584254 |
| 114 | MP0003943_abnormal_hepatobiliary_system | 0.52828668 |
| 115 | MP0008874_decreased_physiological_sensi | 0.51812441 |
| 116 | MP0004782_abnormal_surfactant_physiolog | 0.50177519 |
| 117 | MP0005076_abnormal_cell_differentiation | 0.50027600 |
| 118 | MP0000569_abnormal_digit_pigmentation | 0.49556053 |
| 119 | MP0002136_abnormal_kidney_physiology | 0.48788779 |
| 120 | MP0003656_abnormal_erythrocyte_physiolo | 0.48354601 |
| 121 | MP0003252_abnormal_bile_duct | 0.48348021 |
| 122 | MP0004130_abnormal_muscle_cell | 0.46175977 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 4.72129361 |
| 2 | Chronic otitis media (HP:0000389) | 4.57572494 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.53531310 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.50128002 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 4.38750512 |
| 6 | Recurrent viral infections (HP:0004429) | 4.32852880 |
| 7 | Recurrent fungal infections (HP:0002841) | 4.21610172 |
| 8 | IgM deficiency (HP:0002850) | 4.19278551 |
| 9 | Myositis (HP:0100614) | 4.18763309 |
| 10 | Recurrent bronchitis (HP:0002837) | 4.15917061 |
| 11 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.78146908 |
| 12 | Panhypogammaglobulinemia (HP:0003139) | 3.68106718 |
| 13 | Recurrent cutaneous fungal infections (HP:0011370) | 3.67418413 |
| 14 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.67418413 |
| 15 | Agammaglobulinemia (HP:0004432) | 3.59621267 |
| 16 | Autoimmune thrombocytopenia (HP:0001973) | 3.57737215 |
| 17 | Thrombocytosis (HP:0001894) | 3.55817844 |
| 18 | Vasculitis (HP:0002633) | 3.53174499 |
| 19 | Abnormality of T cells (HP:0002843) | 3.52337735 |
| 20 | Pustule (HP:0200039) | 3.52265554 |
| 21 | Abnormality of T cell number (HP:0011839) | 3.50232001 |
| 22 | Meningitis (HP:0001287) | 3.45578550 |
| 23 | Obstructive lung disease (HP:0006536) | 3.44237983 |
| 24 | Chronic obstructive pulmonary disease (HP:0006510) | 3.44237983 |
| 25 | Mediastinal lymphadenopathy (HP:0100721) | 3.43850780 |
| 26 | Abnormality of T cell physiology (HP:0011840) | 3.38697615 |
| 27 | T lymphocytopenia (HP:0005403) | 3.38636457 |
| 28 | Retrobulbar optic neuritis (HP:0100654) | 3.33137683 |
| 29 | Optic neuritis (HP:0100653) | 3.33137683 |
| 30 | Recurrent skin infections (HP:0001581) | 3.31749092 |
| 31 | * IgG deficiency (HP:0004315) | 3.14665533 |
| 32 | Orchitis (HP:0100796) | 3.11593314 |
| 33 | Lymphopenia (HP:0001888) | 3.08457075 |
| 34 | Nasal polyposis (HP:0100582) | 3.07538717 |
| 35 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.04393942 |
| 36 | Cellulitis (HP:0100658) | 3.01831770 |
| 37 | Abnormality of macrophages (HP:0004311) | 2.94986585 |
| 38 | Abnormality of the fingertips (HP:0001211) | 2.94421733 |
| 39 | Eosinophilia (HP:0001880) | 2.87623372 |
| 40 | Urticaria (HP:0001025) | 2.87180960 |
| 41 | Encephalitis (HP:0002383) | 2.85576508 |
| 42 | IgA deficiency (HP:0002720) | 2.85521075 |
| 43 | B lymphocytopenia (HP:0010976) | 2.83913521 |
| 44 | Abnormality of B cell number (HP:0010975) | 2.83913521 |
| 45 | Abnormality of the prostate (HP:0008775) | 2.80788164 |
| 46 | Thyroiditis (HP:0100646) | 2.80243240 |
| 47 | Abnormality of eosinophils (HP:0001879) | 2.75779889 |
| 48 | Anorexia (HP:0002039) | 2.74210278 |
| 49 | Abnormality of the nasal mucosa (HP:0000433) | 2.71178619 |
| 50 | Lymphoma (HP:0002665) | 2.69853995 |
| 51 | Pulmonary embolism (HP:0002204) | 2.69352317 |
| 52 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.69183554 |
| 53 | Recurrent sinusitis (HP:0011108) | 2.68406873 |
| 54 | Petechiae (HP:0000967) | 2.68149022 |
| 55 | Gastrointestinal stroma tumor (HP:0100723) | 2.67767406 |
| 56 | Increased IgM level (HP:0003496) | 2.67741395 |
| 57 | Leukocytosis (HP:0001974) | 2.67461181 |
| 58 | Gingival bleeding (HP:0000225) | 2.67439788 |
| 59 | Granulocytopenia (HP:0001913) | 2.66597278 |
| 60 | Gangrene (HP:0100758) | 2.66431246 |
| 61 | Inflammation of the large intestine (HP:0002037) | 2.64159157 |
| 62 | Increased IgE level (HP:0003212) | 2.62521371 |
| 63 | Abnormality of the pleura (HP:0002103) | 2.62115347 |
| 64 | Severe combined immunodeficiency (HP:0004430) | 2.60994136 |
| 65 | Hypergammaglobulinemia (HP:0010702) | 2.60224455 |
| 66 | Pulmonary infiltrates (HP:0002113) | 2.59447763 |
| 67 | Basal ganglia calcification (HP:0002135) | 2.58065496 |
| 68 | Stomatitis (HP:0010280) | 2.58055872 |
| 69 | Gastrointestinal inflammation (HP:0004386) | 2.57235514 |
| 70 | Combined immunodeficiency (HP:0005387) | 2.57211171 |
| 71 | Birth length less than 3rd percentile (HP:0003561) | 2.56107060 |
| 72 | Chronic sinusitis (HP:0011109) | 2.55862895 |
| 73 | Gastrointestinal infarctions (HP:0005244) | 2.54901821 |
| 74 | Colitis (HP:0002583) | 2.53426524 |
| 75 | Prostate neoplasm (HP:0100787) | 2.53118164 |
| 76 | Hypochromic anemia (HP:0001931) | 2.48940630 |
| 77 | Autoimmune hemolytic anemia (HP:0001890) | 2.46382305 |
| 78 | Recurrent pneumonia (HP:0006532) | 2.44161345 |
| 79 | Hemoptysis (HP:0002105) | 2.44110267 |
| 80 | Emphysema (HP:0002097) | 2.44096325 |
| 81 | Chronic diarrhea (HP:0002028) | 2.42826354 |
| 82 | Hypochromic microcytic anemia (HP:0004840) | 2.41769379 |
| 83 | Chromsome breakage (HP:0040012) | 2.40934901 |
| 84 | Recurrent lower respiratory tract infections (HP:0002783) | 2.39911574 |
| 85 | Bronchitis (HP:0012387) | 2.34362811 |
| 86 | Acute myeloid leukemia (HP:0004808) | 2.29849643 |
| 87 | Joint swelling (HP:0001386) | 2.29438141 |
| 88 | Periodontitis (HP:0000704) | 2.28992591 |
| 89 | Arterial thrombosis (HP:0004420) | 2.26539012 |
| 90 | Keratoconjunctivitis sicca (HP:0001097) | 2.25502499 |
| 91 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.25210930 |
| 92 | Keratitis (HP:0000491) | 2.24692023 |
| 93 | Episodic fever (HP:0001954) | 2.24651713 |
| 94 | Sepsis (HP:0100806) | 2.23398239 |
| 95 | Verrucae (HP:0200043) | 2.22386417 |
| 96 | Papilloma (HP:0012740) | 2.22386417 |
| 97 | Gingivitis (HP:0000230) | 2.18308191 |
| 98 | Leukopenia (HP:0001882) | 2.17448513 |
| 99 | Spontaneous hematomas (HP:0007420) | 2.17048005 |
| 100 | Entropion (HP:0000621) | 2.15093236 |
| 101 | Interstitial pulmonary disease (HP:0006530) | 2.13282717 |
| 102 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.12260795 |
| 103 | Skin rash (HP:0000988) | 2.10515067 |
| 104 | Prolonged bleeding time (HP:0003010) | 2.10060542 |
| 105 | Stomach cancer (HP:0012126) | 2.09026089 |
| 106 | Glomerulopathy (HP:0100820) | 2.08606509 |
| 107 | Keratoconjunctivitis (HP:0001096) | 2.08312144 |
| 108 | Hematochezia (HP:0002573) | 2.07805250 |
| 109 | Skin ulcer (HP:0200042) | 2.07427237 |
| 110 | Amaurosis fugax (HP:0100576) | 2.07025421 |
| 111 | Neutropenia (HP:0001875) | 2.03894783 |
| 112 | Polyneuropathy (HP:0001271) | 2.03555141 |
| 113 | Osteomyelitis (HP:0002754) | 2.03428685 |
| 114 | Peritonitis (HP:0002586) | 2.03283219 |
| 115 | Vertigo (HP:0002321) | 2.02436790 |
| 116 | Myelodysplasia (HP:0002863) | 2.02197331 |
| 117 | Microcytic anemia (HP:0001935) | 2.02047230 |
| 118 | Clubbing of toes (HP:0100760) | 2.01814597 |
| 119 | Aplastic anemia (HP:0001915) | 2.00330245 |
| 120 | Epistaxis (HP:0000421) | 2.00240098 |
| 121 | Chest pain (HP:0100749) | 1.96973482 |
| 122 | Cheilitis (HP:0100825) | 1.96052398 |
| 123 | Restrictive lung disease (HP:0002091) | 1.95836950 |
| 124 | Abnormality of the pericardium (HP:0001697) | 1.94521719 |
| 125 | Abnormality of the peritoneum (HP:0002585) | 1.93857221 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.78260224 |
| 2 | TXK | 3.12434433 |
| 3 | TYK2 | 2.99024135 |
| 4 | JAK3 | 2.80919404 |
| 5 | IRAK4 | 2.78764053 |
| 6 | MAP3K14 | 2.71717707 |
| 7 | KIT | 2.70686430 |
| 8 | IKBKE | 2.67812083 |
| 9 | BLK | 2.64418342 |
| 10 | TBK1 | 2.40389644 |
| 11 | ZAP70 | 2.15933318 |
| 12 | IKBKB | 2.03490779 |
| 13 | NME2 | 2.02165045 |
| 14 | IRAK3 | 1.99281459 |
| 15 | TEC | 1.87315374 |
| 16 | JAK1 | 1.86047351 |
| 17 | BTK | 1.84993551 |
| 18 | TNK2 | 1.83573612 |
| 19 | SYK | 1.82190531 |
| 20 | CSF1R | 1.71428723 |
| 21 | RIPK4 | 1.66280948 |
| 22 | STK10 | 1.65518203 |
| 23 | BUB1 | 1.58632401 |
| 24 | WEE1 | 1.57691902 |
| 25 | PIM1 | 1.55745382 |
| 26 | NEK2 | 1.54252847 |
| 27 | FGFR4 | 1.53856596 |
| 28 | MAP3K13 | 1.52838465 |
| 29 | PIM2 | 1.52396888 |
| 30 | ACVR1B | 1.52015500 |
| 31 | PLK4 | 1.44394197 |
| 32 | RPS6KA4 | 1.40663217 |
| 33 | ITK | 1.33575126 |
| 34 | LCK | 1.29486701 |
| 35 | FGR | 1.26503032 |
| 36 | CHUK | 1.22602731 |
| 37 | NLK | 1.21323124 |
| 38 | TAOK3 | 1.21046610 |
| 39 | LYN | 1.16130029 |
| 40 | EPHB1 | 1.15861126 |
| 41 | PRPF4B | 1.14426551 |
| 42 | CSK | 1.13800538 |
| 43 | HCK | 1.13394358 |
| 44 | MARK3 | 1.11897811 |
| 45 | EEF2K | 1.09697505 |
| 46 | GRK6 | 1.06290313 |
| 47 | STK4 | 1.06139734 |
| 48 | EIF2AK1 | 1.06133124 |
| 49 | CDC7 | 1.04398040 |
| 50 | FGFR3 | 1.04330570 |
| 51 | STK16 | 1.03256097 |
| 52 | IRAK1 | 1.03056467 |
| 53 | EIF2AK3 | 1.01690625 |
| 54 | BRSK2 | 1.01465986 |
| 55 | GRK7 | 1.01205895 |
| 56 | MAP3K3 | 0.99452174 |
| 57 | EIF2AK2 | 0.98874361 |
| 58 | FRK | 0.97686817 |
| 59 | SRPK1 | 0.94939285 |
| 60 | CLK1 | 0.92149186 |
| 61 | CDK4 | 0.91932729 |
| 62 | MAP3K11 | 0.89966109 |
| 63 | PIK3CG | 0.86785426 |
| 64 | FES | 0.86124309 |
| 65 | HIPK2 | 0.84013064 |
| 66 | MAP3K1 | 0.83649830 |
| 67 | MAP2K3 | 0.81212255 |
| 68 | MST4 | 0.80647703 |
| 69 | ATR | 0.79300042 |
| 70 | TAOK1 | 0.76216253 |
| 71 | FLT3 | 0.74848412 |
| 72 | NEK9 | 0.74414627 |
| 73 | PDK1 | 0.72213981 |
| 74 | LRRK2 | 0.70823012 |
| 75 | TESK2 | 0.70658942 |
| 76 | NUAK1 | 0.64854570 |
| 77 | VRK1 | 0.63969607 |
| 78 | PTK2B | 0.63961914 |
| 79 | DYRK3 | 0.63331874 |
| 80 | KDR | 0.63075769 |
| 81 | JAK2 | 0.62838348 |
| 82 | AURKB | 0.62566327 |
| 83 | PRKD2 | 0.62547173 |
| 84 | TSSK6 | 0.62359406 |
| 85 | CCNB1 | 0.62353973 |
| 86 | EPHA3 | 0.61647471 |
| 87 | PLK1 | 0.59899570 |
| 88 | STK3 | 0.59127049 |
| 89 | FYN | 0.59006109 |
| 90 | MAP2K6 | 0.58731822 |
| 91 | CAMKK2 | 0.58101298 |
| 92 | TGFBR2 | 0.55980822 |
| 93 | STK24 | 0.54591642 |
| 94 | CDC42BPA | 0.54127314 |
| 95 | MKNK2 | 0.53232248 |
| 96 | MAPK7 | 0.52932419 |
| 97 | MAP3K8 | 0.52536389 |
| 98 | TGFBR1 | 0.51459827 |
| 99 | YES1 | 0.51243811 |
| 100 | TLK1 | 0.50673512 |
| 101 | IRAK2 | 0.50493880 |
| 102 | MAPK11 | 0.48611281 |
| 103 | BMPR2 | 0.48557297 |
| 104 | PRKCQ | 0.47488648 |
| 105 | TAOK2 | 0.47103120 |
| 106 | RAF1 | 0.45413764 |
| 107 | RPS6KA5 | 0.44814059 |
| 108 | BRSK1 | 0.44424091 |
| 109 | MATK | 0.44331084 |
| 110 | CDK7 | 0.42665848 |
| 111 | ABL1 | 0.42539306 |
| 112 | MKNK1 | 0.41912875 |
| 113 | MAPK12 | 0.38760462 |
| 114 | ERN1 | 0.38649351 |
| 115 | MAP2K2 | 0.38247267 |
| 116 | CHEK1 | 0.37292153 |
| 117 | CDK12 | 0.37156303 |
| 118 | MAPKAPK2 | 0.37049320 |
| 119 | ALK | 0.37040137 |
| 120 | MAP3K5 | 0.36682212 |
| 121 | ADRBK2 | 0.35990351 |
| 122 | CHEK2 | 0.35960509 |
| 123 | MARK2 | 0.35394617 |
| 124 | ZAK | 0.34747846 |
| 125 | SIK2 | 0.34249214 |
| 126 | MAP3K10 | 0.33543267 |
| 127 | TRPM7 | 0.33529161 |
| 128 | SIK3 | 0.33318713 |
| 129 | PDPK1 | 0.33258223 |
| 130 | RPS6KB2 | 0.33204279 |
| 131 | GRK5 | 0.32744592 |
| 132 | PRKCD | 0.30544131 |
| 133 | STK11 | 0.30527991 |
| 134 | EGFR | 0.30118074 |
| 135 | SGK2 | 0.28216758 |
| 136 | SGK3 | 0.26364002 |
| 137 | IGF1R | 0.24953730 |
| 138 | MAP3K7 | 0.24508890 |
| 139 | ADRBK1 | 0.22050809 |
| 140 | MAPK3 | 0.21094250 |
| 141 | PRKCH | 0.20973062 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 3.45573690 |
| 2 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.79492506 |
| 3 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.71276561 |
| 4 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.51646397 |
| 5 | Allograft rejection_Homo sapiens_hsa05330 | 2.51374726 |
| 6 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.48287168 |
| 7 | Measles_Homo sapiens_hsa05162 | 2.38540614 |
| 8 | DNA replication_Homo sapiens_hsa03030 | 2.30508347 |
| 9 | Leishmaniasis_Homo sapiens_hsa05140 | 2.22733230 |
| 10 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.20076103 |
| 11 | Herpes simplex infection_Homo sapiens_hsa05168 | 2.11326739 |
| 12 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.04541211 |
| 13 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.03352341 |
| 14 | Base excision repair_Homo sapiens_hsa03410 | 1.91464956 |
| 15 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.88705669 |
| 16 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.83280156 |
| 17 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.78406497 |
| 18 | RNA polymerase_Homo sapiens_hsa03020 | 1.76892016 |
| 19 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.76542093 |
| 20 | Homologous recombination_Homo sapiens_hsa03440 | 1.76374570 |
| 21 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.74907455 |
| 22 | Mismatch repair_Homo sapiens_hsa03430 | 1.73175163 |
| 23 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.72736577 |
| 24 | Influenza A_Homo sapiens_hsa05164 | 1.66072726 |
| 25 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.63605285 |
| 26 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.53004580 |
| 27 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.46483754 |
| 28 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.42023677 |
| 29 | Ribosome_Homo sapiens_hsa03010 | 1.39232750 |
| 30 | Legionellosis_Homo sapiens_hsa05134 | 1.37508125 |
| 31 | Proteasome_Homo sapiens_hsa03050 | 1.33558251 |
| 32 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.30419391 |
| 33 | Cell cycle_Homo sapiens_hsa04110 | 1.27819127 |
| 34 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.25472207 |
| 35 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.23443866 |
| 36 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.23041173 |
| 37 | Spliceosome_Homo sapiens_hsa03040 | 1.22365154 |
| 38 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.20415939 |
| 39 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.19549629 |
| 40 | Tuberculosis_Homo sapiens_hsa05152 | 1.18468691 |
| 41 | Hepatitis B_Homo sapiens_hsa05161 | 1.17794879 |
| 42 | Apoptosis_Homo sapiens_hsa04210 | 1.17160529 |
| 43 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.16547790 |
| 44 | RNA transport_Homo sapiens_hsa03013 | 1.16141837 |
| 45 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.15429924 |
| 46 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.15389969 |
| 47 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.14538622 |
| 48 | Pertussis_Homo sapiens_hsa05133 | 1.13429371 |
| 49 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.11841958 |
| 50 | Viral myocarditis_Homo sapiens_hsa05416 | 1.10615757 |
| 51 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.10180093 |
| 52 | Asthma_Homo sapiens_hsa05310 | 1.08674144 |
| 53 | Malaria_Homo sapiens_hsa05144 | 1.06570519 |
| 54 | Shigellosis_Homo sapiens_hsa05131 | 1.06008956 |
| 55 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.04944195 |
| 56 | Basal transcription factors_Homo sapiens_hsa03022 | 1.04596647 |
| 57 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.99870280 |
| 58 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.98374181 |
| 59 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.93201965 |
| 60 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.92551730 |
| 61 | RNA degradation_Homo sapiens_hsa03018 | 0.90316652 |
| 62 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.87034617 |
| 63 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.84912632 |
| 64 | Hepatitis C_Homo sapiens_hsa05160 | 0.84068696 |
| 65 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.79540706 |
| 66 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.77705962 |
| 67 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.74090812 |
| 68 | Other glycan degradation_Homo sapiens_hsa00511 | 0.74090581 |
| 69 | Salmonella infection_Homo sapiens_hsa05132 | 0.72924776 |
| 70 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.72885332 |
| 71 | HTLV-I infection_Homo sapiens_hsa05166 | 0.70556269 |
| 72 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.66279513 |
| 73 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.63114935 |
| 74 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.62762055 |
| 75 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.62276750 |
| 76 | Purine metabolism_Homo sapiens_hsa00230 | 0.58413430 |
| 77 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.57922685 |
| 78 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.57749064 |
| 79 | Platelet activation_Homo sapiens_hsa04611 | 0.57578222 |
| 80 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.55482491 |
| 81 | Lysosome_Homo sapiens_hsa04142 | 0.55155597 |
| 82 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.55002019 |
| 83 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.51812939 |
| 84 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.51163655 |
| 85 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.50422332 |
| 86 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.47058519 |
| 87 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.46300317 |
| 88 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.44124376 |
| 89 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.43998743 |
| 90 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.42982436 |
| 91 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.42408540 |
| 92 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.41700549 |
| 93 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.40933833 |
| 94 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.36688764 |
| 95 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.33961143 |
| 96 | Endocytosis_Homo sapiens_hsa04144 | 0.33606637 |
| 97 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.32391430 |
| 98 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.31778931 |
| 99 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.31209422 |
| 100 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.29206092 |
| 101 | Insulin resistance_Homo sapiens_hsa04931 | 0.28661179 |
| 102 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.28626048 |
| 103 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.28524798 |
| 104 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.28297324 |
| 105 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.27012341 |
| 106 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.26998928 |
| 107 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.25970435 |
| 108 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.25505725 |
| 109 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.25205815 |
| 110 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.25126353 |
| 111 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.24828411 |
| 112 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.23766264 |
| 113 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.23757977 |
| 114 | Phagosome_Homo sapiens_hsa04145 | 0.22579451 |
| 115 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.22233988 |
| 116 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.22079320 |
| 117 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.22003870 |
| 118 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.19188868 |
| 119 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.19047221 |
| 120 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.17882931 |
| 121 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.16893109 |
| 122 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.16690435 |
| 123 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.15931529 |
| 124 | ABC transporters_Homo sapiens_hsa02010 | 0.15545637 |
| 125 | Amoebiasis_Homo sapiens_hsa05146 | 0.14785745 |
| 126 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.14262152 |
| 127 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.14239629 |
| 128 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.08972290 |
| 129 | Prostate cancer_Homo sapiens_hsa05215 | 0.08732843 |
| 130 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.05707142 |

